With this perspective, our analysis of all reported cardiovascular AEFIs across all vaccines within this younger demographic revealed a significant trend of disproportionate reporting of cardiac symptoms post-mRNA COVID-19 vaccination.
← all excerpts
Myocarditis and Pericarditis Post-mRNA COVID-19 Vaccination: Insights from a Pharmacovigilance Perspective.
1
—
—